# HERMES (NCT04595019)

> Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04595019
- Phase: NA
- Status: RECRUITING
- Sponsor: Institute of Cancer Research, United Kingdom
- Conditions: Prostate Cancer
- Interventions: SBRT
- Enrollment: 46
- Primary outcome: Genitourinary (GU) toxicity

## Indexed commentary on HERMES so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=hermes-nct04595019